Jose Mundo-Inciarte
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis.
Journal: Frontiers in immunology
Published: July 22, 2022
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study).
Journal: Rheumatology and therapy
Published: June 02, 2022
Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors.
Journal: Therapeutic advances in musculoskeletal disease
Published: January 17, 2022
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study).
Journal: Rheumatology and therapy
Published: November 10, 2021
Palindromic rheumatism: Evidence of four subtypes of palindromic-like arthritis based in either MEFV or rheumatoid factor/ACPA status.
Journal: Joint bone spine
Published: January 29, 2021
Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis.
Journal: Clinical rheumatology
Published: November 26, 2020
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
Journal: Journal of autoimmunity
Published: October 24, 2020
Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis.
Journal: Therapeutic advances in musculoskeletal disease
Published: July 01, 2020
What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis.
Journal: Advances in therapy
Published: January 16, 2020
Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions.
Journal: Rheumatology and therapy
Published: October 02, 2019
Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making.
Journal: The patient
Published: August 15, 2019
Last Updated: 09/26/2026